Literature DB >> 34309718

Application value of computer-assisted surgery system in pediatric hepatic hemangioma.

Wenli Xiu1, Jie Liu2, Tong Li1, Xiwei Hao1, Hong Liu1,3, Nan Xia3, Yuhe Duan1, Zhong Jiang1, Cong Shang1, Qian Dong4,5.   

Abstract

PURPOSE: To explore the treatment of pediatric hepatic hemangioma and the role of the Hisense computer-assisted surgery (Hisense CAS) system in diagnosis and treatment.
METHODS: We collected the clinical and follow-up data of all pediatric hepatic hemangioma cases in our pediatric surgery department from March 2008 to March 2021 for retrospective analysis. The Hisense CAS system was used to create three-dimensional (3D) reconstructions based on computed tomography data.
RESULTS: There were 71 patients, mainly infants (prenatal to 39 months). There were more males than females (42 vs. 29), and the alpha-fetoprotein level was significantly increased in 8 cases. 3D reconstruction by the Hisense CAS system showed that hepatic artery tracking was helpful for the differential diagnosis of pediatric hepatic hemangioma. Twenty-three children treated with propranolol showed significant differences in the tumour diameter, volume, and tumour-to-liver volume ratio after treatment (all P < 0.05). Compared with early surgical treatment, the curative effect of this approach was obvious.
CONCLUSION: As a non-surgical treatment for symptomatic pediatric hepatic hemangioma, propranolol can replace surgical resection to a certain extent and reduce the proportion of children who need surgical intervention. Hisense CAS has advantages in evaluating the tumour volume before and after propranolol treatment. The liver volume and the liver tumour volume percentage provide new perspectives for evaluating the tumour outcome.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  3D; Children; Computer-assisted; Hepatic hemangioma; Liver; Propranolol

Year:  2021        PMID: 34309718     DOI: 10.1007/s00383-021-04972-5

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  19 in total

1.  Efficacy of propranolol treatment in infantile hepatic haemangioma.

Authors:  Kaiying Yang; Suhua Peng; Linwen Chen; Siyuan Chen; Yi Ji
Journal:  J Paediatr Child Health       Date:  2019-01-09       Impact factor: 1.954

2.  Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: A case report.

Authors:  Giulia Varrasso; Amalia Schiavetti; Silvia Lanciotti; Maria Sapio; Eva Ferrara; Alessandra De Grazia; Anna Clerico
Journal:  Hepatology       Date:  2017-05-09       Impact factor: 17.425

3.  Hepatic hemangioendothelioma of infancy: clinical features of a large cohort of patients and proposed management.

Authors:  Loredana Sana; Pietro Betalli; Michela Bravi; Paola Stroppa; Maurizio Cheli; Aurelio Sonzogni; Lisa Licini; Roberto Agazzi; Michele Colledan; Filippo Parolini; Daniele Alberti; Lorenzo D'Antiga
Journal:  Pediatr Surg Int       Date:  2021-01-29       Impact factor: 1.827

4.  Usefulness of three-dimensional(3D) simulation software in hepatectomy for pediatric hepatoblastoma.

Authors:  Gang Zhang; Xian-Jun Zhou; Cheng-Zhan Zhu; Qian Dong; Lin Su
Journal:  Surg Oncol       Date:  2016-05-20       Impact factor: 3.279

Review 5.  History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis.

Authors:  Maria Gnarra; Gerald Behr; Alison Kitajewski; June K Wu; Sudha A Anupindi; Carrie J Shawber; Nick Zavras; Dimitrios Schizas; Chris Salakos; Konstantinos P Economopoulos
Journal:  World J Clin Pediatr       Date:  2016-08-08

6.  Clinical application of a three-dimensional imaging technique in infants and young children with complex liver tumors.

Authors:  Lin Su; Qian Dong; Hong Zhang; Xianjun Zhou; Yongjian Chen; Xiwei Hao; Xiaofei Li
Journal:  Pediatr Surg Int       Date:  2016-01-25       Impact factor: 1.827

7.  Benign liver tumors in children: outcomes after resection.

Authors:  Sajid S Qureshi; Monica Bhagat; Seema Kembhavi; Tushar Vora; Mukta Ramadwar; Girish Chinnaswamy; Maya Prasad; Nehal Khanna; Sidharth Laskar
Journal:  Pediatr Surg Int       Date:  2015-08-12       Impact factor: 1.827

Review 8.  Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Authors:  Beth A Drolet; Peter C Frommelt; Sarah L Chamlin; Anita Haggstrom; Nancy M Bauman; Yvonne E Chiu; Robert H Chun; Maria C Garzon; Kristen E Holland; Leonardo Liberman; Susan MacLellan-Tobert; Anthony J Mancini; Denise Metry; Katherine B Puttgen; Marcia Seefeldt; Robert Sidbury; Kendra M Ward; Francine Blei; Eulalia Baselga; Laura Cassidy; David H Darrow; Shawna Joachim; Eun-Kyung M Kwon; Kari Martin; Jonathan Perkins; Dawn H Siegel; Robert J Boucek; Ilona J Frieden
Journal:  Pediatrics       Date:  2012-12-24       Impact factor: 7.124

9.  Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring.

Authors:  Ionela Iacobas; Thuy L Phung; Denise M Adams; Cameron C Trenor; Francine Blei; Douglas S Fishman; Adrienne Hammill; Prakash M Masand; Steven J Fishman
Journal:  J Pediatr       Date:  2018-09-21       Impact factor: 4.406

10.  Infantile hepatic hemangiomas associated with high-output cardiac failure and pulmonary hypertension.

Authors:  Xin-Tong Zhang; Wei-Dong Ren; Guang Song; Yang-Jie Xiao; Fei-Fei Sun; Nan Wang
Journal:  BMC Cardiovasc Disord       Date:  2019-10-11       Impact factor: 2.298

View more
  1 in total

1.  Application of 3D Simulation Software in Chemotherapy and Hepatoblastoma Surgery in Children.

Authors:  Jie Liu; Wenli Xiu; Guangqi Duan; Qian Dong
Journal:  Front Surg       Date:  2022-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.